BSR Subscription Information
If you've made it here, you probably have a pretty good idea what we're all about. You've probably already seen one of our free samples, Just in case you came directly here, we'll review what you get with your subscription to BSR's independent biotech sector research.
Each time the BSR Research Team uncovers new information or when a company in our coverage universe releases news that requires additional comment, we publish a BSR Alert. We average around 250 Alerts per year on the two dozen stocks in our coverage universe. This is instant analysis from the BSR Research Team to help you determine a plan of action based upon new information.
At the end of every month, we publish Biotech Monthly. Each issue runs between 40-50 pages. We use Biotech Monthly to debut coverage on new companies or explore issues of science or the markets that impact biotech investors. In each issue, BSR CEO David Miller outlines his view of the macro market. We also update our coverage on the companies in our coverage universe.
All our publications are delivered exclusively online to match the speed of today's investing climate. You never have to wait for the mail carrier to get the news you need.
If you decide you don't like the BSR service for any reason, we'll refund the unused time in your subscription (important restrictions apply so read our Terms and Conditions carefully for details.) To view our research, you are required to download and install a plugin for your Acrobat Reader software. For most users this takes less than 2 minutes and happens virtually automatically the first time you access our research.
Each time the BSR Research Team uncovers new information or when a company in our coverage universe releases news that requires additional comment, we publish a BSR Alert. We average around 250 Alerts per year on the two dozen stocks in our coverage universe. This is instant analysis from the BSR Research Team to help you determine a plan of action based upon new information.
At the end of every month, we publish Biotech Monthly. Each issue runs between 40-50 pages. We use Biotech Monthly to debut coverage on new companies or explore issues of science or the markets that impact biotech investors. In each issue, BSR CEO David Miller outlines his view of the macro market. We also update our coverage on the companies in our coverage universe.
All our publications are delivered exclusively online to match the speed of today's investing climate. You never have to wait for the mail carrier to get the news you need.
| BSR Independent Research Guarantee | |
We accept no compensation from the companies we cover. We are not affiliated with any hedge fund, investment bank, mutual fund, or trading desk. Our biotech stock research is distributed to all Subscribers at exactly the same time Our staff strictly adheres to our industry-best disclosure policy |
If you decide you don't like the BSR service for any reason, we'll refund the unused time in your subscription (important restrictions apply so read our Terms and Conditions carefully for details.) To view our research, you are required to download and install a plugin for your Acrobat Reader software. For most users this takes less than 2 minutes and happens virtually automatically the first time you access our research.
| Introductory Subscription to our research ($210) | Subscribe Now » |
| Three months of new research plus access to the past 45 days of archives. |
| 6-month Subscription to our research ($385) | Subscribe Now » |
| Six months of new research plus full access to the archives. |
| 12 Month Subscription to our research($695) | Subscribe Now » |
| Twelve full months of new research and full access to the archives. |